Treatment

Raludotatug Deruxtecan (R-DXd) clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE2
A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
This study is looking for new ways to treat certain advanced gastrointestinal (GI) cancers. It tests a new medicine called raludotatug deruxtecan (R-DXd). Researchers want to see if this medicine can shrink or get rid of the cancer.
For: Gastrointestinal Cancer
United States · Argentina · Canada